載入...
CSF-1R–dependent lethal hepatotoxicity when agonistic CD40 antibody given before but not after chemotherapy
Cancer immunotherapies are increasingly effective in the clinic, especially immune checkpoint blockade delivered to patients who have T cell-infiltrated tumors. Agonistic CD40 mAb promotes stromal degradation, and in combination with chemotherapy, drives T cell infiltration and de novo responses aga...
Na minha lista:
| 發表在: | J Immunol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4912938/ https://ncbi.nlm.nih.gov/pubmed/27217585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1600146 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|